주식/증권 📈 긍정적 OptimizeRx forecasts $95M-$100M 2026 revenue while maintaining $21M-$25M adjusted EBITDA amid pharma MFN disruption Seeking Alpha - Market News 05/13/2026 12:31:35 AM 21회 원문 기사 보기